So it’s a $1.25 million deal, in what is essentially preclinical technology – why should this move the stock at …
Treatment-resistant depression
StemCells is having an incredible day in the market today, and for good reason. Yesterday, the company filed an SEC filing with regard to a merger agreement. Nothing seems to get investors quite as excited as mergers and …
Soaring
StemCells Inc (STEM) stock plummeted on Tuesday following an announcement about one of its Phase II studies. StemCells said that it will no longer be pursuing its Phase II Pathway Study that was focused on spinal cord …
Stock
The stock's price has nearly tripled since then ... of interest," Public Citizen said in its letter to the two government agencies. The concerns stem
Collins
The strong confidence appeared to stem from a good quarterly report ...
IBM